Extracted from this filing and checked against the source text.
Earnings Releases
SEC 8-K Item 2.02
confidence 0.9
CODEXIS, INC. reported the first quarter ended March 31, 2026 results: revenue $15.2 million, net income $8.7 million, or $0.10 per share, EPS $0.10 per share. Guidance reaffirmed.
- Period
- the first quarter ended March 31, 2026
- Revenue
- $15.2 million
- Net income
- $8.7 million, or $0.10 per share
- EPS
- $0.10 per share
- Guidance
- reaffirmed
- Result
- reported results
Exact text from the filing
First Quarter 2026 Financial Highlights • Total revenues were $15.2 million for the first quarter of 2026 compared to $7.5 million in the first quarter of 2025. The increase was primarily due to the recognition of an additional $6.3 million in revenue from the Merck Technology Transfer agreement which we executed during the fourth quarter of 2025. • Product gross margin was 71% for the first quarter of 2026 compared to 55% in the first quarter of 2025. The increase in gross margin was largely due to a shift in sales toward more profitable products, and declines in less profitable, legacy products. • Research and Development expenses for the first quarter of 2026 were $11.4 million compared to $12.9 million in the first quarter of 2025. The decrease was primarily due to lower allocable costs, partially offset by higher employee-related costs and higher use of outside services. • Selling, General & Administrative expenses for the first quarter of 2026 were $9.8 million compared to $12.4
View on SEC.gov